2024 annual financial data
Aytu BioPharma 2024 Net margin
Direct answer
Net margin was -24.31%.
Operating income was -1,591,000 USD and net income was -15,844,000 USD.
Operating cash flow was -1,388,000 USD.
Get free Aytu BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 65,183,000 USD
- Operating income
- -1,591,000 USD
- Net income
- -15,844,000 USD
- Operating cash flow
- -1,388,000 USD